North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
Perez, E.A., Hillman, D.W., Dentchev, T., Le-Lindqwister, N.A., Geeraerts, L.H., Fitch, T.R., Liu, H., Graham, D.L., Kahanic, S.P., Gross, H.M., Patel, T.A., Palmieri, F.M., Dueck, A.C.
Published in Annals of oncology (01.02.2010)
Published in Annals of oncology (01.02.2010)
Get full text
Journal Article